Mesa Laboratories, Inc.

NASDAQ:MLAB

Hardware, Equipment & Parts

Technology
$137.81 -0.16%

-$0.15 today

Market cap
$774.56M
Beta
0.93
P/E (TTM)
78.3
EPS (TTM)
$1.21
Dividend yield
0.68%
52W Low $55.45High $113.99

Volume 0.07M

Average 0.16M

MLAB Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

Mesa Laboratories, Inc.NASDAQ: MLAB

Net Receivables · Q4 FY2026 · quarter ended Mar 2026

Net receivables rises 5.1% from a year ago

Net receivables stood at $44.1M at the end of Q4 FY2026, up 5.1% from a year earlier and up 9.6% from the prior quarter. Over 3 fiscal years it compounded at +1.2% a year.

Context

  • Net receivables amounted to 10.3% of total assets at the end of Q4 FY2026, up 0.6 pp from a year earlier.
  • Net receivables increased in 2 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether net receivables keeps rising in the next quarterly balance sheet after a +5.1% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$44.1M+9.6% QoQ
Last fiscal yearMar 2026
$44.1M+5.1% YoY
Year agoMar 2025
$41.97M+5.1% since
Net Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+5.1%——
1 year+5.1%——
3-year CAGR+1.2%——
5-year CAGR——
10-year CAGR——

Net Receivables history

USD · from the balance sheet

Latest · FY2026
44.1M USD
Year-over-year change
+5.1%
4-year CAGR
+1.7%

Net Receivables vs competitors

How MLAB compares with its peers on the latest reported figures

  • MLAB's Mar 2026 net receivables of $44.1M is the 8th highest of the 11 companies compared; the peer median is $304.42M.
  • Its year-over-year change of +5.1% is the 5th highest of 11, against a peer median of -1.3%.
  • Net receivables amounts to 10.3% of total assets for MLAB, versus a peer median of 5.7%.
MLAB Competitors Peer median
Net Receivables for MLAB and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
TMOThermo Fisher Scientific Inc.Sep 2026$9.63B -8.6%+3.9%8.4%
AAgilent Technologies, Inc.Jul 2026$1.48B +6.9%+1.9%10.6%
RVTYRevvity, Inc.Jul 2026$709.18M +7.3%+6.7%5.9%
BIOBio-Rad Laboratories, Inc.Jun 2026$441.8M -6.0%-1.5%4.3%
QGENQiagen N.V.Jun 2026$399.05M +3.4%-2.5%6.8%
TECHBio-Techne CorporationSep 2026$209.8M +14.1%+0.3%8.0%
TXG10x Genomics, Inc.Sep 2026$58.76M -39.2%-7.5%5.5%
MLABMesa Laboratories, Inc.Mar 2026$44.1M +5.1%+1.2%10.3%
MRVIMaravai LifeSciences Holdings, Inc.Jun 2026$31.14M +11.7%-44.2%5.2%
PACBPacific Biosciences of California, Inc.Mar 2026$29.35M -7.3%+23.6%3.8%
LABStandard BioTools Inc.Mar 2026$16.64M -53.1%-8.1%2.6%
Peer median (excluding MLAB) $304.42M-1.3%-0.6%5.7%

Competitors are the stored peer set for MLAB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Cash & Equivalents49.35M32.91M28.21M27.32M26.93M
Short-term Investments00000
Net Receivables41.22M42.55M39.06M41.97M44.1M
Inventory24.61M34.64M32.68M25.37M26.37M
Other Current Assets9.14M4.05M3.34M2.87M3.62M
Total Current Assets124.32M118.98M109.35M102.69M106.27M
Property, Plant & Equipment (Net)28.62M28.15M41.44M32.33M48.11M
Goodwill291.17M286.44M180.1M181.76M186.86M
Intangible Assets250.12M216.82M113.75M96.88M83.35M
Long-term Investments00000
Tax Assets1.32M1.08M1.29M1.37M1.5M
Other Non-current Assets11.83M10.37M867K18.32M1.66M
Total Non-current Assets583.05M542.86M337.44M330.66M321.48M
Total Assets707.37M661.83M446.8M433.35M427.75M
Account Payables7.9M6.13M6.04M5.75M4.93M
Short-term Debt000101.05M5.63M
Tax Payables7.96M8.92M1.62M10.63M0
Deferred Revenue14.58M15.69M15.48M14.71M14.72M
Other Current Liabilities0015.49M011.5M
Total Current Liabilities48.06M43.36M44.31M163.96M61.9M
Long-term Debt218.37M183.27M221.7M76.9M145.86M
Deferred Tax Liabilities39.22M34.03M19.78M20.18M20.09M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities7.92M7.69M9M12.47M0
Total Non-current Liabilities265.51M224.99M257.09M109.56M179.6M
Total Liabilities313.57M268.35M301.4M273.52M241.5M
Common Stock313.46M332.08M343.64M358.54M375.35M
Retained Earnings76.68M74.2M(183.49M)(188.94M)(185.75M)
Accumulated OCI3.67M(12.8M)(14.76M)(9.78M)(3.36M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity393.8M393.48M145.39M159.83M186.25M
Total Debt221.13M186.14M231.3M181.47M168.83M
Net Debt171.79M153.23M203.08M154.15M141.9M

Mesa Laboratories, Inc.

NASDAQ:MLAB

Intrinsic Alpha fair value

Locked

Current Price

$137.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.